$47.19
0.38 (-0.80%)
Last updated: May 31, 2026 05:44
Fundamentals Overview
Moderna, Inc. is in the middle of its 52-week range with premium valuation, trading relatively flat today.
Valuation premium
Risk (Beta)
1.06 — in line vol
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Pressures (Sell):
3M vs S&P 500: -17.3%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: C-. Current institutional positions: Buy: 2, Equal Weight: 7, Hold: 1, In Line: 3, Neutral: 4, Overweight: 2, Sector Perform: 4, Underperform: 4, Underweight: 3.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $-1.95; current price is $47.19. That’s a -104.1% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | N/A |
| PEG (TTM) | N/A |
| P/B (TTM) | 2.52 |
| P/S (TTM) | 8.42 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 2.41 |
| Quick Ratio (TTM) | 2.35 |
| Cash Ratio (TTM) | 0.8 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | -1.44% |
| Gross margin (TTM) | -13.89% |
| Operating margin (TTM) | -1.53% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for MRNA.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Goldman Sachs | maintain | Neutral | Neutral | 2026-05-04 |
| UBS | maintain | Neutral | Neutral | 2026-05-04 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2026-05-04 |
| Evercore ISI Group | maintain | In Line | In Line | 2026-05-04 |
| Barclays | maintain | Equal Weight | Equal Weight | 2026-04-02 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-02-23 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2026-02-17 |
| Goldman Sachs | maintain | Neutral | Neutral | 2026-02-17 |
| Evercore ISI Group | maintain | In Line | In Line | 2026-02-17 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-12-12 |
| Piper Sandler | maintain | Overweight | Overweight | 2025-11-21 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2025-11-21 |
| Leerink Partners | maintain | Underperform | Underperform | 2025-11-21 |
| B of A Securities | maintain | Underperform | Underperform | 2025-11-10 |
| Barclays | maintain | Equal Weight | Equal Weight | 2025-11-07 |
| UBS | maintain | Buy | Buy | 2025-10-23 |
| JP Morgan | maintain | Underweight | Underweight | 2025-10-23 |
| Citigroup | maintain | Neutral | Neutral | 2025-10-23 |
| Needham | maintain | Hold | Hold | 2025-10-20 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-10-10 |
| Leerink Partners | maintain | Underperform | Underperform | 2025-08-22 |
| Barclays | maintain | Equal Weight | Equal Weight | 2025-08-04 |
| B of A Securities | maintain | Underperform | Underperform | 2025-07-22 |
| JP Morgan | maintain | Underweight | Underweight | 2025-05-22 |
| UBS | maintain | Buy | Buy | 2025-05-02 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2025-05-02 |
| Evercore ISI Group | maintain | In Line | In Line | 2025-05-02 |
| Barclays | maintain | Equal Weight | Equal Weight | 2025-05-02 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-04-09 |
| JP Morgan | maintain | Underweight | Underweight | 2025-03-21 |